← Anti-Inflammatory Foods

What Is Chronic Inflammation?

How low-grade, persistent inflammation drives heart disease, cancer, diabetes, and autoimmune conditions

Your body uses inflammation to heal cuts, fight infections, and recover from injuries. That's a good thing. But when the immune system stays switched on for weeks, months, or years — even without an obvious threat — the result is chronic inflammation. This slow-burning process damages healthy tissue and is now recognized as a common thread linking heart disease, type 2 diabetes, certain cancers, and autoimmune conditions [1]. You can't feel it the way you feel a swollen ankle, which is part of what makes it dangerous.

Acute vs. Chronic Inflammation

Acute inflammation is the immune system's rapid, targeted response to an injury or pathogen. Immune cells rush to the site, neutralize the threat, and then stand down. The whole process typically resolves within days. Chronic inflammation is fundamentally different: it involves a sustained, low-grade activation of the innate immune system that persists for months to years [1]. Key markers include elevated C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α).

How Chronic Inflammation Drives Disease

Cardiovascular disease. Atherosclerosis is no longer viewed as a simple plumbing problem of cholesterol buildup. Inflammatory cells infiltrate arterial walls, destabilize plaques, and trigger the ruptures that cause heart attacks and strokes [3]. The landmark CANTOS trial demonstrated that reducing inflammation with a targeted antibody (canakinumab) lowered cardiovascular event rates independent of cholesterol levels.

Cancer. Chronic inflammation creates a microenvironment rich in reactive oxygen species and growth factors that promote DNA damage, tumor initiation, and metastasis [2]. An estimated 15-20% of cancers are linked to chronic inflammatory conditions — for example, inflammatory bowel disease increases colorectal cancer risk.

Type 2 diabetes. Excess adipose tissue, especially visceral fat, secretes pro-inflammatory cytokines that interfere with insulin signaling. This inflammation-driven insulin resistance is now understood to be a central mechanism in the progression from metabolic syndrome to full-blown diabetes [4].

Autoimmune conditions. In diseases like rheumatoid arthritis, lupus, and multiple sclerosis, the immune system's inflammatory machinery attacks the body's own tissues. While these conditions have genetic components, environmental triggers — including diet — modulate the severity of the inflammatory response.

Common Drivers

The major lifestyle factors that promote chronic inflammation include poor diet (high in refined sugar, processed foods, and trans fats), physical inactivity, chronic stress, poor sleep, smoking, and excess alcohol consumption [1].

The Evidence Base

Furman et al. (2019) published a comprehensive review in Nature Medicine establishing chronic systemic inflammation as a unifying mechanism across the major non-communicable diseases [1]. The authors coined the term "inflammaging" to describe the age-related increase in baseline inflammatory markers and presented evidence that lifestyle interventions — particularly dietary changes — can meaningfully reduce these markers.

The connection between inflammation and cardiovascular disease has been studied for decades, but the field was transformed by the CANTOS trial (Canakinumab Anti-inflammatory Thrombosis Outcomes Study). Raggi et al. (2018) reviewed the mechanistic evidence showing that inflammatory cells actively participate in every stage of atherosclerosis, from fatty streak formation to plaque rupture [3]. Importantly, individuals with elevated CRP but normal LDL cholesterol still carry significant cardiovascular risk, reinforcing that inflammation is an independent driver.

Grivennikov, Greten, and Karin (2010) mapped the molecular pathways by which chronic inflammation promotes cancer [2]. Their review in Cell detailed how NF-κB signaling, STAT3 activation, and chronic cytokine exposure create a tumor-permissive environment. The paper has been cited over 10,000 times and remains foundational to the field of cancer immunology.

Donath and Shoelson (2011) demonstrated that adipose tissue is not merely a passive energy store but an active endocrine organ that secretes inflammatory mediators [4]. Their work showed that macrophage infiltration of fat tissue produces TNF-α and IL-6, directly impairing insulin receptor signaling and driving the metabolic dysfunction seen in type 2 diabetes. Clinical trials using anti-inflammatory agents (such as salsalate and IL-1β blockers) have shown improved glycemic control, confirming the causal role of inflammation.

Taken together, these findings make a strong case that chronic inflammation is not just a symptom of disease — it is a driver. This understanding has shifted attention toward interventions that address inflammation at its root, with diet emerging as one of the most accessible and well-supported strategies.

References

  1. Chronic Inflammation in the Etiology of Disease Across the Life SpanFurman D, Campisi J, Verdin E, et al.. Nature Medicine, 2019. PubMed 31845267 →
  2. Inflammation and Cancer: Triggers, Mechanisms, and ConsequencesGrivennikov SI, Greten FR, Karin M. Cell, 2010. PubMed 20086228 →
  3. Role of Inflammation in the Pathogenesis of Atherosclerosis and Therapeutic InterventionsRaggi P, Genest J, Giles JT, et al.. Atherosclerosis, 2018. PubMed 29610056 →
  4. Inflammation in Obesity, Diabetes, and Related DisordersDonath MY, Shoelson SE. Immunity, 2011. PubMed 23902960 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.